174 related articles for article (PubMed ID: 22697263)
1. Treating idiopathic pulmonary fibrosis: current opportunities and future challenges.
Richeldi L
Clin Respir J; 2012 Jul; 6(3):129-30. PubMed ID: 22697263
[No Abstract] [Full Text] [Related]
2. Idiopathic pulmonary fibrosis and pirfenidone.
Collard HR
Eur Respir J; 2010 Apr; 35(4):728-9. PubMed ID: 20356985
[No Abstract] [Full Text] [Related]
3. FDA panel likes new treatment for idiopathic pulmonary fibrosis.
Morrow T
Manag Care; 2010 Apr; 19(4):53-4. PubMed ID: 20446566
[No Abstract] [Full Text] [Related]
4. Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation?
Papiris SA; Kagouridis K; Kolilekas L; Triantafillidou C; Tsangaris I; Manali ED
Eur Respir J; 2012 Sep; 40(3):794-5. PubMed ID: 22941551
[No Abstract] [Full Text] [Related]
5. InterMune and Boehringer blaze trails for idiopathic pulmonary fibrosis drugs.
Kingwell K
Nat Rev Drug Discov; 2014 Jul; 13(7):483-4. PubMed ID: 24981347
[No Abstract] [Full Text] [Related]
6. Pirfenidone treatment of idiopathic pulmonary fibrosis.
Azuma A
Ther Adv Respir Dis; 2012 Apr; 6(2):107-14. PubMed ID: 22333982
[TBL] [Abstract][Full Text] [Related]
7. Hot off the breath: A big step forward for idiopathic pulmonary fibrosis.
Ryerson CJ; Collard HR
Thorax; 2014 Sep; 69(9):791-2. PubMed ID: 24996636
[No Abstract] [Full Text] [Related]
8. Novel treatments for idiopathic pulmonary fibrosis.
Spagnolo P
Am J Med; 2015 May; 128(5):447-9. PubMed ID: 25613299
[No Abstract] [Full Text] [Related]
9. Pirfenidone: significant treatment effects in idiopathic pulmonary fibrosis.
Hilberg O; Simonsen U; du Bois R; Bendstrup E
Clin Respir J; 2012 Jul; 6(3):131-43. PubMed ID: 22697264
[TBL] [Abstract][Full Text] [Related]
10. Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions.
Raghu G; Selman M
Am J Respir Crit Care Med; 2015 Feb; 191(3):252-4. PubMed ID: 25635489
[No Abstract] [Full Text] [Related]
11. Two therapies now available for idiopathic pulmonary fibrosis.
Morrow T
Manag Care; 2014 Dec; 23(12):47-8. PubMed ID: 25939185
[No Abstract] [Full Text] [Related]
12. Pirfenidone for idiopathic pulmonary fibrosis.
Bouros D
Lancet; 2011 May; 377(9779):1727-9. PubMed ID: 21571363
[No Abstract] [Full Text] [Related]
13. Therapeutic advances in idiopathic pulmonary fibrosis.
George G; Vaid U; Summer R
Clin Pharmacol Ther; 2016 Jan; 99(1):30-2. PubMed ID: 26502087
[No Abstract] [Full Text] [Related]
14. Pirfenidone.
Richeldi L; Yasothan U; Kirkpatrick P
Nat Rev Drug Discov; 2011 Jul; 10(7):489-90. PubMed ID: 21837822
[No Abstract] [Full Text] [Related]
15. A new era of drug therapy for idiopathic pulmonary fibrosis.
Crooks MG; Hart SP
Lancet Respir Med; 2014 Dec; 2(12):964-6. PubMed ID: 25466348
[No Abstract] [Full Text] [Related]
16. Pharmacological therapy does not contribute to survival in idiopathic pulmonary fibrosis.
Ishii H; Kushima H; Komiya K; Mizunoe S; Kadota J
Respiration; 2013; 86(1):86-7. PubMed ID: 23594834
[No Abstract] [Full Text] [Related]
17. Forced vital capacity in idiopathic pulmonary fibrosis--FDA review of pirfenidone and nintedanib.
Karimi-Shah BA; Chowdhury BA
N Engl J Med; 2015 Mar; 372(13):1189-91. PubMed ID: 25806913
[No Abstract] [Full Text] [Related]
18. [Idiopathic pulmonary fibrosis: treatment with pirfenidone].
Cano-Jiménez E
Arch Bronconeumol; 2012 Oct; 48 Suppl 2():16-8. PubMed ID: 23630972
[No Abstract] [Full Text] [Related]
19. Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis.
Loeh B; Drakopanagiotakis F; Bandelli GP; von der Beck D; Tello S; Cordani E; Rizza E; Barrocu L; Markart P; Seeger W; Guenther A; Albera C
Am J Respir Crit Care Med; 2015 Jan; 191(1):110-3. PubMed ID: 25551350
[No Abstract] [Full Text] [Related]
20. Pirfenidone for the treatment of idiopathic pulmonary fibrosis.
Poletti V; Ravaglia C; Tomassetti S
Expert Rev Respir Med; 2014 Oct; 8(5):539-45. PubMed ID: 25113033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
